Variant report
Variant | esv3348902 |
---|---|
Chromosome Location | chr5:70496996-70534894 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:319)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr5:70505333-70505618 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr5:70523358-70523643 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr5:70505255-70505621 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr5:70523279-70523646 | GM12878 | blood: | n/a | n/a |
5 | BCL11A | chr5:70505318-70505550 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr5:70497555-70497741 | GM12878 | blood: | n/a | n/a |
7 | BCL11A | chr5:70498899-70499099 | GM12878 | blood: | n/a | n/a |
8 | BCL11A | chr5:70523365-70523610 | GM12878 | blood: | n/a | n/a |
9 | BCL11A | chr5:70505340-70505585 | GM12878 | blood: | n/a | n/a |
10 | BCL11A | chr5:70516928-70517128 | GM12878 | blood: | n/a | n/a |
11 | BCL11A | chr5:70523346-70523575 | GM12878 | blood: | n/a | n/a |
12 | BCL11A | chr5:70518726-70518945 | GM12878 | blood: | n/a | n/a |
13 | BCL11A | chr5:70534302-70534501 | GM12878 | blood: | n/a | n/a |
14 | BCL11A | chr5:70500697-70500916 | GM12878 | blood: | n/a | n/a |
15 | CBX3 | chr5:70509467-70509864 | K562 | blood: | n/a | n/a |
16 | CBX3 | chr5:70527463-70527784 | K562 | blood: | n/a | n/a |
17 | CEBPB | chr5:70509412-70509821 | K562 | blood: | n/a | n/a |
18 | CEBPB | chr5:70509438-70509715 | K562 | blood: | n/a | n/a |
19 | CEBPB | chr5:70526709-70527074 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | CEBPB | chr5:70527518-70527681 | K562 | blood: | n/a | n/a |
21 | CEBPB | chr5:70527402-70527811 | K562 | blood: | n/a | n/a |
22 | CEBPB | chr5:70526860-70527075 | K562 | blood: | n/a | n/a |
23 | CEBPD | chr5:70527476-70527752 | K562 | blood: | n/a | n/a |
24 | CEBPD | chr5:70509420-70509831 | K562 | blood: | n/a | n/a |
25 | CTCF | chr5:70509405-70509708 | K562 | blood: | n/a | n/a |
26 | CTCF | chr5:70509402-70509681 | K562 | blood: | n/a | n/a |
27 | CTCF | chr5:70527330-70527721 | K562 | blood: | n/a | n/a |
28 | CTCF | chr5:70527389-70527761 | K562 | blood: | n/a | n/a |
29 | CTCF | chr5:70521763-70522262 | K562 | blood: | n/a | n/a |
30 | CTCF | chr5:70521714-70522131 | K562 | blood: | n/a | n/a |
31 | CTCF | chr5:70503627-70504189 | K562 | blood: | n/a | n/a |
32 | CTCF | chr5:70503766-70504062 | K562 | blood: | n/a | n/a |
33 | CTCF | chr5:70527329-70527874 | K562 | blood: | n/a | n/a |
34 | CTCF | chr5:70521871-70522139 | K562 | blood: | n/a | n/a |
35 | CTCF | chr5:70509337-70509708 | K562 | blood: | n/a | n/a |
36 | CTCF | chr5:70503834-70504038 | K562 | blood: | n/a | n/a |
37 | EBF1 | chr5:70505268-70505624 | GM12878 | blood: | n/a | n/a |
38 | EBF1 | chr5:70518752-70518963 | GM12878 | blood: | n/a | n/a |
39 | EBF1 | chr5:70505246-70505619 | GM12878 | blood: | n/a | n/a |
40 | EBF1 | chr5:70523293-70523649 | GM12878 | blood: | n/a | n/a |
41 | EBF1 | chr5:70500723-70500934 | GM12878 | blood: | n/a | n/a |
42 | EBF1 | chr5:70523270-70523644 | GM12878 | blood: | n/a | n/a |
43 | EP300 | chr5:70514623-70514909 | GM12878 | blood: | n/a | n/a |
44 | EP300 | chr5:70532647-70532933 | GM12878 | blood: | n/a | n/a |
45 | EP300 | chr5:70498788-70499115 | GM12878 | blood: | n/a | n/a |
46 | EP300 | chr5:70500680-70500922 | GM12878 | blood: | n/a | n/a |
47 | EP300 | chr5:70518709-70518951 | GM12878 | blood: | n/a | n/a |
48 | EP300 | chr5:70516817-70517144 | GM12878 | blood: | n/a | n/a |
49 | FOSL2 | chr5:70520821-70521052 | HepG2 | liver: | n/a | n/a |
50 | FOSL2 | chr5:70516010-70516272 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GTF2H2-6 | chr5:70529887-70530059 | NONHSAT102010 |
2 | lnc-GTF2H2-6 | chr5:70528927-70529141 | NONHSAT102010 |
3 | lnc-BDP1-5 | chr5:70504655-70505021 | NONHSAT102007 |
4 | lnc-GTF2H2-5 | chr5:70525720-70525924 | NONHSAT102009 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254133 | TF binding region |
GUSBP9 | TF binding region |
ENSG00000254276 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200257143 | chr5:70497244-70497245 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs200920672 | chr5:70497267-70497268 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs201896045 | chr5:70497611-70497612 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs574210324 | chr5:70497752-70497753 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs541256329 | chr5:70497763-70497764 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs551147651 | chr5:70497768-70497769 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs62372707 | chr5:70497784-70497785 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs569541154 | chr5:70497797-70497798 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs370078861 | chr5:70497925-70497926 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs200722857 | chr5:70498061-70498062 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs201933443 | chr5:70498074-70498075 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs76097976 | chr5:70498086-70498087 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs201437353 | chr5:70504889-70504890 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs76696757 | chr5:70507180-70507181 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs568319940 | chr5:70509259-70509260 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs367939117 | chr5:70526194-70526195 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs371965848 | chr5:70526305-70526306 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs375237421 | chr5:70526343-70526344 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs368275512 | chr5:70526427-70526428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372921711 | chr5:70526643-70526644 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs576725494 | chr5:70526728-70526729 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs375820362 | chr5:70526752-70526753 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs544088889 | chr5:70526763-70526764 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs369171176 | chr5:70526784-70526785 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs562373921 | chr5:70526800-70526801 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs372532358 | chr5:70526821-70526822 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs573308005 | chr5:70526869-70526870 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs376886976 | chr5:70527054-70527055 | Enhancers Weak transcription Strong transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs150988224 | chr5:70527256-70527257 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs541014822 | chr5:70527313-70527314 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs200202691 | chr5:70527356-70527357 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs559121479 | chr5:70527399-70527400 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs67205590 | chr5:70527760-70527761 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs112141777 | chr5:70528973-70528974 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 21346763 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:70525000-70526600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr5:70525000-70526600 | Weak transcription | Fetal Intestine Large | intestine |
3 | chr5:70525600-70528000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
4 | chr5:70525600-70528000 | Weak transcription | Primary hematopoietic stem cells | blood |
5 | chr5:70525800-70528000 | Weak transcription | Ovary | ovary |
6 | chr5:70525800-70528200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr5:70525800-70528200 | Weak transcription | Fetal Brain Female | brain |
8 | chr5:70526600-70527000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr5:70526600-70527000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr5:70526600-70527000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr5:70526600-70527000 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
12 | chr5:70526600-70527200 | Strong transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr5:70526600-70527200 | Strong transcription | Fetal Intestine Large | intestine |
14 | chr5:70526600-70527400 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr5:70527000-70527200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr5:70527000-70527400 | Genic enhancers | Primary mononuclear cells fromperipheralblood | Blood |
17 | chr5:70527200-70527400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr5:70527200-70527400 | Enhancers | Lung | lung |
19 | chr5:70527200-70528800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr5:70527200-70528800 | Weak transcription | Fetal Intestine Large | intestine |
21 | chr5:70527400-70528200 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |